The Medicines for Human Use and Medical Devices(Fees Amendments) Regulations 2003

The Secretary of State, being a Minister designated for the purposes of section 2(2) of the European Communities Act 19721 in relation to medicinal products2, in exercise of the powers conferred upon him by the said section 2(2), the Secretary of State, with the consent of the Treasury, in exercise of the powers conferred upon him by section 56(1) and (2) of the Finance Act 19733, the Secretary of State, the Department of Health, Social Services and Public Safety and the Department of Agriculture and Rural Development, acting jointly and with the consent of the Treasury, in exercise of powers conferred upon them by section 1(1) and (2) of the Medicines Act 19714, or, as the case may be, powers conferred by those provisions and now vested in them5, and in each case in exercise of all other powers respectively enabling them in that behalf, after consultation in accordance with section 129(6) of the Medicines Act 19686 with such organisations as appear to them to be representative of interests likely to be substantially affected, hereby make the following Regulations: